A 52-year-old woman undergoes staging laparotomy for apparent Stage I ovarian cancer. Regarding the management of early-stage ovarian cancer, all of the following statements are true EXCEPT:

Explanation

## Management of Early-Stage Epithelial Ovarian Cancer ### Chemotherapy Regimens in Early-Stage Disease **Key Point:** BEP (bleomycin, etoposide, cisplatin) is NOT the standard chemotherapy regimen for early-stage ovarian cancer. The preferred regimen is **BEP or carboplatin-paclitaxel (TC)**, but BEP is rarely used in modern practice. **High-Yield:** The standard adjuvant chemotherapy for early-stage ovarian cancer is: - **Carboplatin + paclitaxel (TC)** — 3–6 cycles - BEP is an older regimen used historically for germ cell tumors, not epithelial ovarian cancer - Bleomycin is not part of standard ovarian cancer chemotherapy ### Surgical Staging in Early-Stage Disease **Clinical Pearl:** Comprehensive surgical staging is critical because: - Many apparent Stage I cancers are actually Stage III when properly staged - Staging includes: - Pelvic and para-aortic lymphadenectomy - Peritoneal biopsies - Omentectomy - Inspection of all peritoneal surfaces - Inadequate staging leads to understaging and undertreatment ### Treatment Algorithm by Stage and Grade ```mermaid flowchart TD A[Stage I Ovarian Cancer]:::outcome --> B{Grade and substage?}:::decision B -->|IA, Grade 1| C[Observation only<br/>if adequately staged]:::action B -->|IA, Grade 2-3| D[Adjuvant TC x 3]:::action B -->|IB-IC or any Grade 2-3| E[Adjuvant TC x 3-6]:::action C --> F[Follow-up surveillance]:::action D --> F E --> F ``` ### Fertility-Sparing Surgery **High-Yield:** In young women with Stage IA, Grade 1 ovarian cancer: - Unilateral salpingo-oophorectomy (USO) is appropriate - Uterus and contralateral ovary are preserved - Allows future pregnancy - Requires comprehensive staging to confirm Stage IA - No adjuvant chemotherapy needed if Stage IA, Grade 1 ### Summary Table | Stage | Grade | Adjuvant Chemotherapy | Notes | |-------|-------|----------------------|-------| | IA | 1 | None (if adequately staged) | Observation only | | IA | 2–3 | TC × 3 cycles | Chemotherapy indicated | | IB–IC | Any | TC × 3–6 cycles | Staging-dependent | | II–III | Any | TC × 6 cycles | Standard therapy | **Warning:** BEP is used for **germ cell tumors** (dysgerminoma, yolk sac tumor), not epithelial ovarian cancer. Do not confuse regimens. [cite:Williams Gynecology 4e Ch 33]